Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

AuthID
P-00N-KNN
29
Author(s)
Mateos, MV
·
Dimopoulos, MA
·
Cavo, M
·
Suzuki, K
·
Jakubowiak, A
·
Knop, S
·
Doyen, C
·
Nagy, Z
·
Kaplan, P
·
[+9]·
Fujisaki, T
·
Garg, M
·
Chiu, C
·
Wang, J
·
Carson, R
·
Crist, W
·
Deraedt, W
·
Nguyen, H
·
Qi, M
·
San Miguel, J
1
Group Author(s)
ALCYONE Trial Investigators
Document Type
Article
Year published
2018
Published
in NEW ENGLAND JOURNAL OF MEDICINE, ISSN: 0028-4793
Volume: 378, Issue: 6, Pages: 519-529 (11)
Indexing
Publication Identifiers
Pubmed: 29231133
Scopus: 2-s2.0-85042083059
Wos: WOS:000424335200007
Source Identifiers
ISSN: 0028-4793
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Mateos, MV;   2 Dimopoulos, MA;   3 Cavo, M;
4 Suzuki, K;   5 Jakubowiak, A;   6 Knop, S;
7 Doyen, C;   8 Lucio, P;   9 Nagy, Z;
10 Kaplan, P;   11 Pour, L;   12 Cook, M;
13 Grosicki, S;   14 Crepaldi, A;   15 Liberati, AM;
16 Campbell, P;   17 Shelekhova, T;   18 Yoon, SS;
19 Iosava, G;   20 Fujisaki, T;   21 Garg, M;
22 Chiu, C;   23 Wang, J;   24 Carson, R;
25 Crist, W;   26 Deraedt, W;   27 Nguyen, H;
28 Qi, M;   29 San Miguel, J;